世界のIVIgリキッド市場2020-2025:50ml、25ml

LP Informationが発行した調査報告書(LPI21MA06864)
◆英語タイトル:Global IVIg Liquid Market Growth 2020-2025
◆商品コード:LPI21MA06864
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年1月
◆ページ数:163
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥402,600見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥603,900見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥805,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「IVIgリキッドの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、50ml、25mlなど、用途別には、免疫不全、自己免疫疾患、急性感染症などに区分してまとめた調査レポートです。IVIgリキッドのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・IVIgリキッドの世界市場概要(サマリー)
・IVIgリキッドの企業別販売量・売上
・IVIgリキッドの企業別市場シェア
・IVIgリキッドの世界市場規模 2015年-2020年:種類別(50ml、25ml)
・IVIgリキッドの世界市場規模 2015年-2020年:用途別(免疫不全、自己免疫疾患、急性感染症)
・IVIgリキッドの米州市場規模(アメリカ、カナダ、メキシコなど)
・IVIgリキッドのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・IVIgリキッドの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・IVIgリキッドの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・IVIgリキッド市場の成長要因・課題・動向
・IVIgリキッドの世界市場予測 2021年-2025年
・IVIgリキッドの米州市場予測(アメリカ、カナダ、メキシコなど)
・IVIgリキッドのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・IVIgリキッドの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・IVIgリキッドの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・IVIgリキッドの世界市場予測:種類別(50ml、25ml)
・IVIgリキッドの世界市場予測:用途別(免疫不全、自己免疫疾患、急性感染症)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the IVIg Liquid market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in IVIg Liquid business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of IVIg Liquid market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the IVIg Liquid, covering the supply chain analysis, impact assessment to the IVIg Liquid market size growth rate in several scenarios, and the measures to be undertaken by IVIg Liquid companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
50ml
25ml

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Immunodeficiency
Autoimmune Disease
Acute Infection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Takeda
CBPO
Grifols
Octapharma
Biotest
CSL
CNBG
Kedrion
Shanghai RAAS
Hualan Bio
LFB Group
Sichuan Yuanda Shuyang
BPL

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global IVIg Liquid consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of IVIg Liquid market by identifying its various subsegments.
Focuses on the key global IVIg Liquid manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the IVIg Liquid with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of IVIg Liquid submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global IVIg Liquid Consumption 2015-2025
2.1.2 IVIg Liquid Consumption CAGR by Region
2.2 IVIg Liquid Segment by Type
2.2.1 50ml
2.2.2 25ml
2.3 IVIg Liquid Consumption by Type
2.3.1 Global IVIg Liquid Consumption Market Share by Type (2015-2020)
2.3.2 Global IVIg Liquid Revenue and Market Share by Type (2015-2020)
2.3.3 Global IVIg Liquid Sale Price by Type (2015-2020)
2.4 IVIg Liquid Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 IVIg Liquid Consumption by Application
2.5.1 Global IVIg Liquid Consumption Market Share by Type (2015-2020)
2.5.2 Global IVIg Liquid Value and Market Share by Type (2015-2020)
2.5.3 Global IVIg Liquid Sale Price by Type (2015-2020)

3 Global IVIg Liquid by Company
3.1 Global IVIg Liquid Sales Market Share by Company
3.1.1 Global IVIg Liquid Sales by Company (2018-2020)
3.1.2 Global IVIg Liquid Sales Market Share by Company (2018-2020)
3.2 Global IVIg Liquid Revenue Market Share by Company
3.2.1 Global IVIg Liquid Revenue by Company (2018-2020)
3.2.2 Global IVIg Liquid Revenue Market Share by Company (2018-2020)
3.3 Global IVIg Liquid Sale Price by Company
3.4 Global IVIg Liquid Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global IVIg Liquid Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players IVIg Liquid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 IVIg Liquid by Regions
4.1 IVIg Liquid by Regions
4.2 Americas IVIg Liquid Consumption Growth
4.3 APAC IVIg Liquid Consumption Growth
4.4 Europe IVIg Liquid Consumption Growth
4.5 Middle East & Africa IVIg Liquid Consumption Growth

5 Americas
5.1 Americas IVIg Liquid Consumption by Countries
5.1.1 Americas IVIg Liquid Consumption by Countries (2015-2020)
5.1.2 Americas IVIg Liquid Value by Countries (2015-2020)
5.2 Americas IVIg Liquid Consumption by Type
5.3 Americas IVIg Liquid Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC IVIg Liquid Consumption by Regions
6.1.1 APAC IVIg Liquid Consumption by Regions (2015-2020)
6.1.2 APAC IVIg Liquid Value by Regions (2015-2020)
6.2 APAC IVIg Liquid Consumption by Type
6.3 APAC IVIg Liquid Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe IVIg Liquid by Countries
7.1.1 Europe IVIg Liquid Consumption by Countries (2015-2020)
7.1.2 Europe IVIg Liquid Value by Countries (2015-2020)
7.2 Europe IVIg Liquid Consumption by Type
7.3 Europe IVIg Liquid Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa IVIg Liquid by Countries
8.1.1 Middle East & Africa IVIg Liquid Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa IVIg Liquid Value by Countries (2015-2020)
8.2 Middle East & Africa IVIg Liquid Consumption by Type
8.3 Middle East & Africa IVIg Liquid Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 IVIg Liquid Distributors
10.3 IVIg Liquid Customer

11 Global IVIg Liquid Market Forecast
11.1 Global IVIg Liquid Consumption Forecast (2021-2025)
11.2 Global IVIg Liquid Forecast by Regions
11.2.1 Global IVIg Liquid Forecast by Regions (2021-2025)
11.2.2 Global IVIg Liquid Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global IVIg Liquid Forecast by Type
11.8 Global IVIg Liquid Forecast by Application

12 Key Players Analysis
12.1 Takeda
12.1.1 Company Information
12.1.2 IVIg Liquid Product Offered
12.1.3 Takeda IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Takeda Latest Developments
12.2 CBPO
12.2.1 Company Information
12.2.2 IVIg Liquid Product Offered
12.2.3 CBPO IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CBPO Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 IVIg Liquid Product Offered
12.3.3 Grifols IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Octapharma
12.4.1 Company Information
12.4.2 IVIg Liquid Product Offered
12.4.3 Octapharma IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Biotest
12.5.1 Company Information
12.5.2 IVIg Liquid Product Offered
12.5.3 Biotest IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Biotest Latest Developments
12.6 CSL
12.6.1 Company Information
12.6.2 IVIg Liquid Product Offered
12.6.3 CSL IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 CSL Latest Developments
12.7 CNBG
12.7.1 Company Information
12.7.2 IVIg Liquid Product Offered
12.7.3 CNBG IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CNBG Latest Developments
12.8 Kedrion
12.8.1 Company Information
12.8.2 IVIg Liquid Product Offered
12.8.3 Kedrion IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Kedrion Latest Developments
12.9 Shanghai RAAS
12.9.1 Company Information
12.9.2 IVIg Liquid Product Offered
12.9.3 Shanghai RAAS IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Shanghai RAAS Latest Developments
12.10 Hualan Bio
12.10.1 Company Information
12.10.2 IVIg Liquid Product Offered
12.10.3 Hualan Bio IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hualan Bio Latest Developments
12.11 LFB Group
12.11.1 Company Information
12.11.2 IVIg Liquid Product Offered
12.11.3 LFB Group IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 LFB Group Latest Developments
12.12 Sichuan Yuanda Shuyang
12.12.1 Company Information
12.12.2 IVIg Liquid Product Offered
12.12.3 Sichuan Yuanda Shuyang IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sichuan Yuanda Shuyang Latest Developments
12.13 BPL
12.13.1 Company Information
12.13.2 IVIg Liquid Product Offered
12.13.3 BPL IVIg Liquid Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 BPL Latest Developments

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のIVIgリキッド市場2020-2025:50ml、25ml(Global IVIg Liquid Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。